MINI Act

Both the US House and US Senate have introduced bipartisan legislation to maintain incentives for investment in cardiovascular research and development. The Maintaining Investments in New Innovation Act, commonly referred to as The MINI Act, promotes and supports medical innovation in the United States by extending the amount of time certain “genetically targeted” therapies are on market before they are subject to regulations signed into law by the Inflation Reduction Act.